TBGH/DFWBGH 2021 Regional Benefits Forum

  • 14 Sep 2021
  • 15 Sep 2021
  • 2 sessions
  • 14 Sep 2021, 11:45 AM 2:15 PM (CDT)
  • 15 Sep 2021, 11:45 AM 2:15 PM (CDT)
  • Wherever You Might Like

Employers and employees have one thing in common after a year and a half of coping with the disruptions and challenges of the COVID pandemic:  Both are ready to get “back to the future” in a new normal work-life and workplace. 

The future in benefits strategies adapted to post-pandemic working world will be the focus of our upcoming 2021 TBGH Regional Benefits Forum, presented virtually on September 14 & 15.

The following Sessions will be presented virtually at 11:45 am–2:15 pm on both days, 2 per day.

Tuesday, Sept. 14, 12:00 pm -12:55 pm

Session 1: Advanced Primary Care at the Epicenter of Healthcare’s Future

Advanced Primary Care (APC) holds great promise for employers to improve employee health, health outcomes, and healthcare costs.  APC is a population-focused care delivery method that is superior to the traditional fee-for-service model because it provides true care coordination that cannot be achieved in FFS.  Here’s why: APC enhances patient access, allows more time with patients, integrates with behavioral health, and provides referrals to specialists based on quality.  In this session, three types of APC models will be presented by leaders of healthcare organizations experienced in APC.

Moderator: Chris Skisak, Executive Director, Houston Business Coalition on Health


  • Clive Fields, MD, Co-Founder & Chief Medical Officer, VillageMD 
  • Juliet Breeze, MD, Founder & CEO, Next Level Urgent Care & Next level Medical
  • Dr. Patrick Carter, Medical Director for Care Coordination and Quality Improvement and Department Chair of Family Medicine, Kelsey Seybold  
  • Andrea Cockrell, Administrative Services Manager, City of Plano

Tuesday, Sept. 14, 1:10 pm–2:00 pm

SESSION 2: COVID Impact of Delayed or Avoided Cancer Care on Employee Health and Healthcare Costs

Cancer screenings and treatment saw a sharp decline during the COVID pandemic.  The delays and disruptions in cancer screenings and care delivery, coupled with fear and avoidance by those at risk for cancer, will likely lead to greater severity, more complications, worse outcomes, and higher healthcare costs.  In this session, we will discuss the impact of delayed cancer screenings and treatment during COVID and employer strategies to mitigate the fallout on employees’ health and healthcare costs.


  • Debra Patt, MD, PhD, MBA, Executive Vice President, Texas Oncology & Community Oncology Alliance
  • Todd Sachs, MD, Chief Medical officer, AccessHope 
  • David Hines, Executive Director, Employee Benefits, Metro Nashville Public School District 

Wednesday, Sept.15, 11:55 am–1:00 pm

SESSION 3:  Quest for Total Health & Wellbeing: Tackling the Obvious & the Obscure

Obesity and related conditions are the fastest growing health issues in the U.S.  More than two-thirds of Americans are overweight or obese, and at higher risk for diabetes, heart disease, musculoskeletal disorders, and mental illness, including depression.  The COVID pandemic has exacerbated every one of these conditions, especially obesity, making weight management as both a health and a business imperative for employers.  In this session, you will gain a clear understanding and appreciation for tackling obesity as the front door to total health and wellbeing of your employees.

Moderator: Scott Conard, MD, Converging Health

Part 1: COVID’s connection to T2Diabetes & Related Conditions 

  • Jake Olsen, Director Account Management, Forte  
  • Maribel Borysyuk, Outcomes Liaison, Associate Director, Sanofi

Part 2: Managing total person health: 

  • Jason Lurk, Medical Accounts Associate Director, Novo Nordisk
  • Isabel Alencar, Vice President of Clinical Services, Catapult Health 

Wednesday, Sept.15, 1:15 am–2:05 pm

SESSION 4:  Value-driven pharmacy benefit strategies to curb costs and improve outcomes

Employers expect their health benefits costs to increase 5.3 percent this year, to an average $15,500 per employee.  Costly biologic therapies and wasteful spending due to medication misuse, overuse or underuse are key drivers behind employers’ rising healthcare costs.  Fortunately, employers have two relatively new instruments in their drug-management toolkit: Biosimilars and Comprehensive Medication Management.  Biosimilars offer less expensive alternatives to their branded biologic counterparts, and Comprehensive Medication Management optimizes medication therapies, which reduces costs and improves patient outcomes.

In this session, you will learn how employers can bring Biosimilars and Comprehensive Medication Management into their value-based benefits programs to support a healthy workforce and bottom line.

Moderator: Sandra Morris, Benefits Consultant, GMTRx Institute 


  • Kim Foerster, Director, Pharmacy Account Management, BCBS-MI 
  • Sandra Morris, Senior Advisor, GMTRx Institute

Register Once to Attend One or All sessions


Thank you to our sponsors.